Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Effect of Molar Replacement on Glycemic Control in Adults With Uncontrolled Type 2 Diabetes (DIABETEETH)

18 giugno 2026 aggiornato da: Assistance Publique - Hôpitaux de Paris

Type 2 diabetes (T2D) is a major global health issue, affecting about 9.2% of adults in Europe. Although treatment begins with lifestyle changes and medications, up to half of patients fail to achieve adequate blood sugar control, highlighting the need for new strategies. People with T2D often have poorer oral health, including missing teeth and more severe periodontal disease. This reduces masticatory (chewing) efficiency, which depends largely on having functional molars. Impaired chewing can influence food choices and overall diet quality. This study explores whether improving chewing ability by replacing missing molars can help patients with uncontrolled T2D improve their diet and blood sugar levels. The hypothesis is that restoring masticatory efficiency with implant-supported prostheses will lead to healthier eating habits and better glycemic control.

This study is a multicenter, randomized controlled trial with two groups:

  • Intervention group: receives molar replacement with implant-supported prostheses plus standard diabetes care.
  • Control group: receives standard diabetes care only. The main goal is to assess the effect of this intervention on glycemic control after 9 months, measured by changes in HbA1c levels. All participants will receive a comprehensive oral health assessment and necessary dental care (e.g., treatment of infections, cavities, and periodontal disease), which may itself improve quality of life and potentially support better diabetes control by reducing inflammation. For the intervention group, restoring molars is expected to improve chewing efficiency, enhance quality of life, and encourage healthier dietary habits, which could improve diabetes outcomes. Additionally, since poor chewing ability is linked to higher cardiovascular risk, the intervention may also help reduce heart disease risk.

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Descrizione dettagliata

Diabetes is one of the leading causes of death and disability worldwide. The current prevalence of the most common form of diabetes, type 2 diabetes (T2D), is estimated at 9.2% among individuals aged 20-79 years in Europe. First-line management of T2D relies on therapeutic lifestyle modifications (diet and physical activity), with pharmacological treatment added in case of failure. Despite the wide range of available pharmacological options, up to 50% of individuals living with T2D who adhere to treatment do not achieve their glycemic targets. There is therefore a need to identify alternative strategies to reduce blood glucose levels.

Individuals living with T2D generally have poorer oral health than the general population, with a reduced number of teeth and more frequent and severe periodontitis. This results in lower masticatory efficiency compared with the general population, as masticatory efficiency mainly depends on the number of teeth in occlusion, particularly the presence of premolars and molars. The persistence of at least one pair of first molars plays a major role in determining the ability to grind and mix food. Masticatory efficiency influences dietary choices.

It is currently unknown whether improving masticatory efficiency in individuals with uncontrolled diabetes, through the replacement of missing teeth, modifies dietary habits and improves diabetes control. The hypothesis of this study is that, in individuals with uncontrolled T2D, restoring masticatory efficiency by replacing missing molars with fixed implant-supported prostheses will lead to improved dietary quality and better glycemic control.

This is a multicenter, open-label, two-arm parallel-group, superiority randomized controlled trial. Participants will be randomized in a 1:1 ratio to receive either:

Intervention: replacement of one pair of molars with implant-supported prostheses in addition to standard care for the management of type 2 diabetes (T2D);

Control: standard care for the management of T2D only.

The primary objective is to evaluate the impact of replacing one pair of molars with implant-supported prostheses in individuals living with uncontrolled T2D and reduced masticatory efficiency, at 9 months post-randomization, on glycemic control.

The primary endpoint is the difference in HbA1c between randomization and 9 months post-randomization.

Regarding individual benefits, all patients included in the study will benefit from a comprehensive oral health assessment allowing screening for dental caries, dental infections, periodontal disease, oral mucosal pathologies (including pre-cancerous and cancerous lesions and oral candidiasis), xerostomia, malocclusion, and temporomandibular joint disorders. These conditions are more frequent in patients with T2D. All included patients will subsequently receive dental care aimed at eliminating infectious foci and treating any carious lesions and periodontal diseases that may be present. The assessment and dental care will improve patients' oral health and contribute to a better oral health-related quality of life. They may also potentially improve diabetes control, as infectious foci and periodontal diseases are responsible for local and systemic inflammation that complicates glycemic control.

For patients included in the intervention group, restoration of a functional molar pair in occlusion is expected to significantly increase masticatory efficiency and further improve oral health-related quality of life. The intervention may also lead to changes in dietary habits toward a healthier and more balanced diet. Such dietary changes could be beneficial for diabetes control. As reduced masticatory efficiency is associated with a higher risk of coronary heart disease, the intervention may also reduce the risk of cardiovascular disease. The implants and implant-supported prostheses used to restore a molar pair are provided as part of the research.

Tipo di studio

Interventistico

Iscrizione (Stimato)

140

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • Adults aged between 18 and 75 years
  • Type 2 diabetes diagnosed for more than 6 months, according to the diagnostic criteria of the International Diabetes Federation
  • Insufficiently controlled type 2 diabetes (HbA1c between 7.5% and 10.5%)
  • Type 2 diabetes under stable treatment for at least 3 months (no initiation or discontinuation of antidiabetic treatments, and no change in basal insulin dose greater than ±50% compared with the initial dose)
  • Presence of all teeth up to the second premolars, i.e. presence of maxillary and mandibular incisors, canines and premolars. The absence of premolars extracted for orthodontic reasons or due to agenesis is not taken into account. Teeth replaced by fixed tooth- or implant-supported prostheses are considered present.
  • Absence of functional molar pairs not compensated by a partial prosthesis, or presence of only one functional molar pair. The absence of a pair may be due to the absence of both molars or only one molar (molar without an antagonist). Third molars are not taken into account.

Exclusion Criteria:

  • Recent diabetes (< 6 months), intensified insulin therapy (≥ 3 injections/day) or insulin pump use
  • Type 1 diabetes
  • Type 2 diabetes with HbA1c > 10.5%
  • Comorbidities contraindicating part of the oral rehabilitation (particularly implant placement) or impacting masticatory efficiency, such as end-stage renal disease or stroke within the past 6 months
  • Smoking >10 cigarettes/day
  • Presence of severe crestal defects, insufficient prosthetic space, malocclusions and/or parafunctions contraindicating part of the oral rehabilitation
  • Severe periodontitis (Stage III or IV, Grade C)
  • Cancerous or precancerous lesions of the oral mucosa
  • Allergy to anesthetics or antibiotics required for dental surgery
  • Pregnant or breastfeeding woman
  • Participation in another interventional study involving human participants or being within the exclusion period following a previous study involving human participants, where applicable
  • No affiliation to a social security scheme
  • Patient benefiting from State Medical Aid (AME)
  • Individual deprived of liberty or under legal protection measures
  • Refusal or inability to provide written informed consent

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Ricerca sui servizi sanitari
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Replacement of one pair of molars
Replacement of one pair of molars with implant-supported prostheses in addition to standard care for the management of type 2 diabetes (T2D)

The intervention group will receive one or two implant-supported crowns necessary to restore a functional pair of molars in occlusion.

The implant or implants placed will be made of commercially pure titanium, with a tapered cylindrical shape and dimensions (diameter and length) adapted to each clinical situation. After a minimum healing period of 3 months, fabrication of the crown(s) can begin. Once osseointegration of the implant has been confirmed, a physical or digital impression will be taken to manufacture the abutment and the implant-supported crown. The abutments and crowns will be produced using CAD/CAM technology, in titanium and ceramic respectively (milling followed by finishing). The crowns may be either cement-retained or screw-retained, depending on the clinical situation.

Nessun intervento: Standard care
Standard care for the management of type 2 diabetes only.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in HbA1c (%) from baseline (randomization) to 9 months post-randomization.
Lasso di tempo: 9 months
Biological tests such as HbA1c will be carried out in a community laboratory or in one of the hospitals affiliated with a participating research center. Physicians (diabetologists) from these centers will provide the necessary prescriptions for these tests.
9 months

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in masticatory efficiency assessed by two-colour chewing gum mixing test (Variance of Hue) from randomization to 9 months post-randomization.
Lasso di tempo: 9 months
Objective masticatory efficiency will be assessed using a validated two-colour chewing gum mixing test. Participants will chew a bi-coloured chewing gum for 20 chewing cycles. The chewed gum will then be flattened into a 1-mm thick wafer, scanned, and analyzed using ImageJ software. The score is based on the quantification of residual unmixed colour pigments. Lower scores indicate better colour mixing and therefore better masticatory efficiency, whereas higher scores indicate poorer masticatory efficiency.
9 months
Subjective masticatory efficiency : Change in Chewing Function Questionnaire (CFQ) total score from randomization to 9 months post-randomization.
Lasso di tempo: 9 months
Subjective masticatory efficiency will be assessed using the Chewing Function Questionnaire (CFQ), a 10-item questionnaire. Each item is rated on a 5-point Likert scale ranging from 0 ("never") to 4 ("very often"). The total score is calculated as the sum of all item scores and ranges from 0 to 40. Higher scores indicate greater chewing difficulties and therefore poorer subjective masticatory efficiency, whereas lower scores indicate fewer chewing difficulties. A score of 0 indicates the absence of chewing-related problems.
9 months
Change in weight, from randomization to 9 months post-randomization.
Lasso di tempo: 9 months
Weight are measured during visits in one of the hospitals affiliated with a participating research center.
9 months
Change in body mass index from randomization to 9 months post-randomization.
Lasso di tempo: 9 months
BMI are measured during visits in one of the hospitals affiliated with a participating research center.
9 months
Change in triglycerides from randomization to 9 months post-randomization.
Lasso di tempo: 9 months
Triglycerides measures are carried out in a community laboratory or in one of the hospitals affiliated with a participating research center. Physicians (diabetologists) from these centers will provide the necessary prescriptions for these tests.
9 months
Change in HDL cholesterol from randomization to 9 months post-randomization.
Lasso di tempo: 9 months
HDL cholesterol measures are carried out in a community laboratory or in one of the hospitals affiliated with a participating research center. Physicians (diabetologists) from these centers will provide the necessary prescriptions for these tests.
9 months
Change in total cholesterol from randomization to 9 months post-randomization.
Lasso di tempo: 9 months
Total cholesterol measures are carried out in a community laboratory or in one of the hospitals affiliated with a participating research center. Physicians (diabetologists) from these centers will provide the necessary prescriptions for these tests.
9 months
Change in glucose Time in Range (TIR; 70-180 mg/dL) assessed by continuous glucose monitoring over 15 days from randomization to 9 months post-randomization.
Lasso di tempo: 9 months
Glycemia is measured continuously over 15 days using a FreeStyle Libre sensor.
9 months
HbA1c values at randomization and at 3 and 6 months post-randomization.
Lasso di tempo: 6 months
HbA1c will be measured in a community laboratory or in one of the hospitals affiliated with a participating research center. Physicians (diabetologists) from these centers will provide the necessary prescriptions for these tests.
6 months
triglyceride values at randomization and at 3 and 6 months post-randomization.
Lasso di tempo: 6 months
Triglycerides will be measured in a community laboratory or in one of the hospitals affiliated with a participating research center. Physicians (diabetologists) from these centers will provide the necessary prescriptions for these tests.
6 months
HDL cholesterol values at randomization and at 3 and 6 months post-randomization.
Lasso di tempo: 6 months
HDL cholesterol will be measured in a community laboratory or in one of the hospitals affiliated with a participating research center. Physicians (diabetologists) from these centers will provide the necessary prescriptions for these tests.
6 months
Total cholesterol values at randomization and at 3 and 6 months post-randomization.
Lasso di tempo: 6 months
Total cholesterol will be measured in a community laboratory or in one of the hospitals affiliated with a participating research center. Physicians (diabetologists) from these centers will provide the necessary prescriptions for these tests.
6 months
Mean cost of replacing one functional molar pair with implant-supported prostheses.
Lasso di tempo: 14 months
Individual cost for each person included in the intervention group. For the intervention group, the cost of oral rehabilitation is calculated based on the patient's dental record.
14 months
Change in nutritional quality scores assessed by UK Diabetes and Diet Questionnaire (UKDDQ) questionnaire from randomization to 9 months post-randomization.
Lasso di tempo: 9 months
Dietary quality will be assessed using the UK Diabetes and Diet Questionnaire (UKDDQ). The questionnaire consists of 20 items, each scored from 0 to 5, where 0 represents the healthiest dietary option and 5 the least healthy option. The UKDDQ score is calculated by summing the item scores and dividing the total by 20. Scores range from 0 to 5, with lower scores indicating healthier dietary habits and higher scores indicating poorer dietary habits.
9 months
Change in quality of lifes scores assessed by Oral Health Impact Profile-14 (OHIP-14) total score from randomization to 9 months post-randomization.
Lasso di tempo: 9 months
Oral health-related quality of life will be assessed using the Oral Health Impact Profile-14 (OHIP-14) questionnaire. The questionnaire contains 14 items, each scored on a 5-point scale ranging from 0 ("never") to 4 ("very often"). The total score is calculated by summing all item scores and ranges from 0 to 56. Lower scores indicate a better oral health-related quality of life and less impact of oral conditions on daily life, whereas higher scores indicate a greater negative impact of oral health problems.
9 months

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

15 novembre 2026

Completamento primario (Stimato)

15 agosto 2030

Completamento dello studio (Stimato)

15 agosto 2030

Date di iscrizione allo studio

Primo inviato

8 giugno 2026

Primo inviato che soddisfa i criteri di controllo qualità

18 giugno 2026

Primo Inserito (Effettivo)

24 giugno 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

24 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

18 giugno 2026

Ultimo verificato

1 aprile 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • APHP251243
  • N° IDRCB : 2025-A02621-48 (Altro identificatore: IDRCB)

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Diabete di tipo 2

3
Sottoscrivi